CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.

The serum expression of a novel tumour marker, CA 242, defined by monoclonal antibody C 242, was studied in 179 patients with pancreatic cancer. The results were compared with CA 19-9, CA 50 and CEA. CA 242 is a carbohydrate closely related, but not identical, to CA 19-9 and CA 50. The overall sensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Haglund, C., Lundin, J., Kuusela, P., Roberts, P. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033366/
https://www.ncbi.nlm.nih.gov/pubmed/8080735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033366/
https://www.ncbi.nlm.nih.gov/pubmed/8080735

Ejemplares similares